INCLUSION OF PATIENTS Sample Clauses

INCLUSION OF PATIENTS. The Sponsor reserves the right to interrupt the inclusion of patients in the Trial under any of the following circumstances: If the Principal Investigator does not include, without justification accepted by the Parties, the agreed number of patients during the designated time period. If the total number of patients that must be included in the Trial by the different researchers participating in the Trial is reached when a multicentre Trial is involved. Patients may not be recruited after the end of the trial inclusion period, unless the ECRm approves the corresponding modification of the Protocol.
INCLUSION OF PATIENTS. The Sponsor reserves the right to interrupt the inclusion of patients in the Study under any of the following circumstances: If the Principal Investigator does not include, without justification accepted by the Parties, the agreed number of patients during the designated time period. If the total number of patients that must be included in the Study by the different researchers participating in the Study is reached when a multicentre Study is involved. Patients may not be recruited after the end of the Study inclusion period, unless the ECRm approves the corresponding modification of the Protocol. Likewise, patients included in the Study may be eligible to participate in an internal research project of the Oncology / Medical Hematology / Radiation Oncology Department of the HUVH, approved by the ECRm, provided that it does not interfere with the performance and evaluation of the Study that is the subject of this Contract.
INCLUSION OF PATIENTS. The Sponsor reserves the right to interrupt the inclusion of patients in the Trial under any of the following circumstances: If the Principal Investigator does not include, without justification accepted by the Parties, the agreed number of patients during the designated time period. If the total number of patients that must be included in the Trial by the different researchers participating in the Trial is reached when a multicentre Trial is involved. Patients may not be recruited after the end of the trial inclusion period, unless the ECRm approves the corresponding modification of the Protocol. Likewise, the patients included in the Trial may be susceptible to participate in an internal research project of the Oncology / Medical Hematology / Radiation Oncology Department of the HUVH, approved by the ECRm, provided that it does not interfere with the performance and evaluation of the Trial that is the object of this Contract.
INCLUSION OF PATIENTS. The Sponsor reserves the right to discontinue inclusion of patients in any of the following cases: If the principal investigator does not include the agreed-upon number of patients during the designated time frame. When, in the case of a multicenter study, the total number of patients to be included in the study has already been reached by other investigators. In either case, the Sponsor agrees to notify the CREC and the principal investigator.
INCLUSION OF PATIENTS. The sponsor reserves the right to stop further inclusion of patients in any of the following circumstances: Should the principal investigator, without justification acceptable to both parties, fail to include the number of patients agreed to during the specified recruitment period. In the case of multi-centre trials, should the total number of patients to be included in the trial by the different participating investigators have been reached. Unless the enrolment period has been extended by written agreement of the parties, or the trial discontinued for justified reasons or by mutual agreement, the inclusion of the patients shall have been completed by the date of expiry to the trial.
INCLUSION OF PATIENTS. The Trial Sponsor reserves the right to interrupt the inclusion of patients under any of the following circumstances: If the Principal Investigator does not include, without justification accepted by the Parties, the agreed number of patients during the designated time period. If the total number of patients that must be included in the Trial by the different researchers participating in the Trial is reached when a multicentre Trial is involved. On the date when the Trial ends, the inclusion of the number of patients anticipated must have occurred, unless the Parties agree in writing to extend the time period for inclusion of patients. Despite the foregoing, the patients included in the Trial may be able to participate in internal research of the HUVH Medical Oncology service, approved by the ECRm, provided that this does not interfere with the performance and evaluation of the Trial that is the subject matter of the Contract.
INCLUSION OF PATIENTS. (Remove redundant alternative / text, include necessary text) New patients may be included in Compassionate Use Program (CUP) / Compassionate Use Named Patient (CUNP) until the pharmaceutical drug is granted MA. New patients may be included in Compassionate Use Program (CUP) / Compassionate Use Named Patient (CUNP) [x] months from the Framework Agreement entry into force. The Parties may agree to extend the period of inclusion beyond this. Patients can be included until marketed packages is available for purchase in Norway. Such inclusion after marketing authorization, but before available marketed packaging, must be done by agreement with the supplier. “Marketed packaging available for purchase” means the packaging, which has Norwegian marketing authorization and list price, is available for order at the pharmaceutical wholesaler(s). Available for purchase is independent of government funding. Regardless of the first paragraph, the Supplier has the right to close inclusion of new patients with effect from two (2) months after written notice has been sent (from the date notice is sent). The duration of the inclusion period, even upon notice to close inclusion, cannot be less than three (3) months.
INCLUSION OF PATIENTS. ‌ (Remove redundant alternative / text, include necessary text) New patients may be included in Compassionate Use Program (CUP) / Compassionate Use Named Patient (CUNP) until the pharmaceutical drug is granted MA. New patients may be included in Compassionate Use Program (CUP) / Compassionate Use Named Patient (CUNP) [x] months from the Framework Agreement entry into force. The Parties may agree to extend the period of inclusion beyond this. Regardless of the first paragraph, the Supplier has the right to close inclusion of new patients with effect from two (2) months after written notice has been sent (from the date notice is sent). The duration of the inclusion period, even upon notice to close inclusion, cannot be less than three (3) months.

Related to INCLUSION OF PATIENTS

  • CERTIFICATION OF AGREEMENT In accordance with section 170LT of the Workplace Relations Act 1996, I now certify the attached written agreement. This agreement shall come into force from 16 February 2004 and shall remain in force until 31 October 2005. BY THE COMMISSION: Printed by authority of the Commonwealth Government Printer <Price code 70> TABLE OF CONTENTS Subject Matter Clause No. Page No. Accident Pay 29 32 All-In Payments 34 34 Alpine Areas 14.1.(b) 15 Altona Area Allowance 14.2.(a) 16 Amenities 37 35 Apprentices 22.(a) 23 Australian Materials 41 37 Casual Labour 12.2 13 Classification Structure & Rates of Pay, Allowances 13 14 Clothing Issue & Safety Footwear 40 36 Co-Invest (Long Service Leave) 27 31 Commitments 3 5 Consultation 8 7 Demolition Work 14.1.(d) 16 Dispute Settlement Procedure 9 8 Drugs & Alcohol 38 35 Employment & Termination 12 12 Fares & Travel Allowance 15 17 Fast Food Allowance 14.1.(a) 15 Further Flexibilities 23 24 Geelong, Altona, Portland, etc Metals Agreements 14.3 16 Geographic Area, and Sector Specific Allowances, Conditions and Exceptions 14 15 Hearing Tests 11.(2) 10 Heavy Blocks 11.(9) 12 Hours Of work, Rostered Days Off, and Protection of Leisure Time 17 17 Inclement Weather 24 24 Income Protection 28.1 31 Income Protection & Trauma Insurance 28 31 Induction Procedures 11.(4) 11 Job Stewards/Delegates 36 34 Job Xxxxxxx/Delegate Facilities 36.2 35 Journey Accidents 30 32 Latrobe Valley Allowance 14.2.(b) 16 Leisure Time Protected 17.3 18 Living Away from Home Allowance 16 17 Major Events 14.1.(c) 15 Metal Trades Labour Hire Agreement 14.4 16 Negotiation of a Subsequent Agreement 43 37 No Extra Claims 44 38 Objectives of the Agreement 2 5 Overtime 17.2 18 Parties and Persons Bound 4 6 Payment of Wages 19 21 Period of Operation 6 6 Picnic Day 31 33 Project Agreements 5.2 6 Project Pre-Commencement Conference 18 21 Protective Clothing & Equipment 11.(3) 10 Pyramid Subcontracting 35 34 Redundancy 25 30 Rehabilitation Program 39 35 Relationship to Parent Award and Victorian Building Industry Agreement 7 6 Right of Entry & Representation 33 33 Rostered Days Off 17.4 19 Safety Dispute Resolution 10 8 Scope & Application 5 6 Security & Continuity of Employment 32 33 Service Core Allowance 14.2.(c) 16 Signatories 45 39 Superannuation 26 30 Termination of Employment 12.3 13 Time & Wages Records 19.1 21 Title 1 5 Tool Storage 20 22 Toxic Substances 11(8) 11 Training & Related Matters 22 23 Trauma Insurance 28.2 32 Waste Minimisation, Recycling and Environmental Issues 42 37 Workplace Safety 11 10 Appendix A – Classification Structure 40 Appendix B – Rates of Pay 1. From 1 December 2002 2. From 1 March 2003 3. From 1 March 2004 4. From 1 March 2005 41 Appendix C – Site Allowances 51 Appendix D – Drugs & Alcohol Policy 54 Appendix E – Passenger and Material Lifts 61 Appendix F – Amenities 63 Appendix G – Shopping Centres 66 Appendix H – Trade Union Training Leave 67 Appendix I – Sector Appendix 70

  • Inclusion and accessibility The institution will provide support to incoming mobile participants with fewer opportunities, according to the requirements of the Erasmus Charter for Higher Education. Information and assistance can be provided by the following contact points and information sources: Although a brief overview is provided in this agreement, more detailed information is sent to the nominees in order for them to prepare their exchange.

  • Certification Regarding Debarment Party certifies under pains and penalties of perjury that, as of the date that this Agreement is signed, neither Party nor Party’s principals (officers, directors, owners, or partners) are presently debarred, suspended, proposed for debarment, declared ineligible or excluded from participation in Federal programs, or programs supported in whole or in part by Federal funds.

  • CERTIFICATION CLAUSES The CONTRACTOR CERTIFICATION CLAUSES contained in the document CCC 04/2017 are hereby incorporated by reference and made a part of this Agreement by this reference as if attached hereto.

  • Medicaid Notification of Termination Requirements Party shall follow the Department of Vermont Health Access Managed-Care-Organization enrollee-notification requirements, to include the requirement that Party provide timely notice of any termination of its practice.

  • CERTIFICATION REGARDING DEBARMENT, SUSPENSION, INELIGIBILITY AND VOLUNTARY EXCLUSION

  • Certification Regarding Lobbying Applicable to Grants, Subgrants, Cooperative Agreements, and Contracts Exceeding $100,000 in Federal Funds Submission of this certification is a prerequisite for making or entering into this transaction and is imposed by section 1352, Title 31, U.S. Code. This certification is a material representation of fact upon which reliance was placed when this transaction was made or entered into. Any person who fails to file the required certification shall be subject to a civil penalty of not less than $10,000 and not more than $100,000 for each such failure. The undersigned certifies, to the best of his or her knowledge and belief, that: (1) No Federal appropriated funds have been paid or will be paid by or on behalf of the undersigned, to any person for influencing or attempting to influence an officer or employee of any agency, a Member of Congress, an officer or employee of congress, or an employee of a Member of Congress in connection with the awarding of a Federal contract, the making of a Federal grant, the making of a Federal loan, the entering into a cooperative agreement, and the extension, continuation, renewal, amendment, or modification of a Federal contract, grant, loan, or cooperative agreement.

  • Submission of Agreement Submission of this Lease to Tenant for signature does not constitute a reservation of space or an option to acquire a right of entry. This Lease is not binding or effective until execution by and delivery to both Landlord and Tenant.

  • Certification Regarding Prohibition of Boycotting Israel (Tex Gov. Code 2271)

  • Certification of Residency, etc The Customer certifies that it is a resident of the United States and agrees to notify the Bank of any changes in residency. The Bank may rely upon this certification or the certification of such other facts as may be required to administer the Bank’s obligations under this Agreement. The Customer will indemnify the Bank against all losses, liability, claims or demands arising directly or indirectly from any such certifications.